Cited by 850Multiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersOcular Diseases and Behçet’s Syndrome

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

Open access

Sato, Douglas Kazutoshi, Callegaro, Dagoberto, Lana-Peixoto, Marco Aurelio, Waters, Patrick J., Jorge, Frederico M. de Haidar, Takahashi, Toshiyuki, Nakashima, Ichiro, Apostolos-Pereira, Samira Luisa, Talim, Natalia, Simm, Renata Faria, Lino, Angelina Maria Martins, Misu, Tatsuro, Leite, Maria Isabel, Aoki, Masashi, Fujihara, Kazuo·2014·Neurology

DOI 10.1212/wnl.0000000000000101PMC PMC3937859

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To evaluate clinical features among patients with neuromyelitis optica spectrum disorders (NMOSD) who have myelin oligodendrocyte glycoprotein (MOG) antibodies, aquaporin-4 (AQP4) antibodies, or seronegativity for both antibodies. METHODS: Sera from patients diagnosed with NMOSD in 1 of 3 centers (2 sites in Brazil and 1 site in Japan) were tested for MOG and AQP4 antibodies using cell-based assays with live transfected cells. RESULTS: Among the 215 patients with NMOSD, 7.4% (16/215) were positive for MOG antibodies and 64.7% (139/215) were positive for AQP4 antibodies. No patients were positive for both antibodies. Patients with MOG antibodies represented 21.1% (16/76) of the patients negative for AQP4 antibodies. Compared with patients with AQP4 antibodies or patients who were seronegative, patients with MOG antibodies were more frequently male, had a more restricted phenotype (optic nerve more than spinal cord), more frequently had bilateral simultaneous optic neuritis, more often had a single attack, had spinal cord lesions distributed in the lower portion of the spinal cord, and usually demonstrated better functional recovery after an attack. CONCLUSIONS: Patients with NMOSD with MOG antibodies have distinct clinical features, fewer attacks, and better recovery than patients with AQP4 antibodies or patients seronegative for both antibodies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000000101

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Revised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,568
The spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,182
The clinical course of neuromyelitis optica (Devic’s syndrome)
Wingerchuk, D. M., Hogancamp, W. E., O’Brien, P. C., & Weinshenker, B. G. (1999) · Neurology · doi:10.1212/wnl.53.5.1107 · Cited by 1,819
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Shiga, Y., Kanaoka, C., Fujimori, J., et al. (2007) · Brain · doi:10.1093/brain/awm062 · Cited by 633
Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies: A Comparative Study
Kitley, J., Waters, P., Woodhall, M., Leite, M. I., Murchison, A., George, J., Küker, W., Chandratre, S., Vincent, A., & Palace, J. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5857 · Cited by 597
Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays
Waters, P. J., McKeon, A., Leite, M. I., Rajasekharan, S., Lennon, V. A., Villalobos, A., Palace, J., Mandrekar, J. N., Vincent, A., Bar-Or, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318248dec1 · Cited by 526
Self-citation
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
Mader, S., Gredler, V., Schanda, K., Rostasy, K. M., Dujmović, I., Pfaller, K., Lutterotti, A., Jarius, S., Pauli, F. D., Kuenz, B., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-184 · Cited by 449
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Kitley, J., Woodhall, M., Waters, P., Leite, M. I., Devenney, E., Craig, J., Palace, J., & Vincent, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31826aac4e · Cited by 445
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein
O’Connor, K. C., McLaughlin, K. A., Jager, P. L. D., Chitnis, T., Bettelli, E., Xu, C., Robinson, W. H., Cherry, S. V., Bar‐Or, A., Banwell, B., et al. (2007) · Nature Medicine · doi:10.1038/nm1488 · Cited by 419
The spectrum of MOG autoantibody-associated demyelinating diseases
Reindl, M., Pauli, F. D., Rostasy, K. M., & Berger, T. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.118 · Cited by 376

Show all 21 references

Sorted by citations

Items 401–500 of 848

Comparison between optic neuritis associated with antibody against myelin oligodendrocyte glycoprotein and presumed idiopathic optic perineuritis
Jang, Y., Kim, S., Yun, Y. I., Lee, H., Kim, S.-J., Jung, J. H., & Shin, J. H. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04371-z · Cited by 16
Discrepancy in clinical and laboratory profiles of NMOSD patients between AQP4 antibody positive and negative: can NMOSD be diagnosed without AQP4 antibody?
Chu, F., Shi, M., Liu, C., & Zhu, J. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad053 · Cited by 15
AXL+SIGLEC6+ dendritic cells in cerebrospinal fluid and brain tissues of patients with autoimmune inflammatory demyelinating disease of CNS
Kang, J., Kim, M., Yoon, D., Kim, W., Choi, S. J., Kwon, Y. N., Kim, W., Park, S., Sung, J., Park, M., et al. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109686 · Cited by 15
Clinical characteristics of autoimmune optic neuritis
Kawachi, I. (2017) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12354 · Cited by 15
Myelin oligodendrocyte glycoprotein-IgG-associated optic neuritis
Chun, B. Y., & Cestari, D. M. (2018) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000520 · Cited by 15
Two Japanese cases of anti-MOG antibody-associated encephalitis that mimicked neuro-Behçet's disease
Fujimori, J., Takahashi, T., Matsumoto, Y., Fujihara, K., Takai, Y., Misu, T., & Nakashima, I. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577002 · Cited by 15
Anti-MOG (Myelin Oligodendrocyte Glycoprotein)–Positive Severe Optic Neuritis with Optic Disc Ischaemia and Macular Star
Moura, F. C., Sato, D. K., Rimkus, C. D. M., Apóstolos‐Pereira, S. L., de Oliveira, L. M., Leite, C. C., Fujihara, K., Monteiro, M. L. R., & Callegaro, D. (2015) · Neuro-Ophthalmology · doi:10.3109/01658107.2015.1084332 · Cited by 15
A case of anti-myelin oligodendrocyte glycoprotein (MOG) and anti-N-methyl-D-aspartate (NMDA) receptor antibody-positive encephalitis with optic neuritis
Nagata, S., Nishimura, Y., & Mitsuo, K. (2018) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001194 · Cited by 15
Comparison of MOG and AQP4 antibody seroprevalence in Korean adults with inflammatory demyelinating CNS diseases
Hyun, J., Lee, H. L., Jeong, W. K., Lee, H. J., Shin, J. H., Min, J., Kim, B., Kim, S. W., Shin, H. Y., Oh, J., et al. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520948213 · Cited by 15
Clinico‐radiological characteristics of anti‐myelin oligodendrocyte glycoprotein antibody‐associated autoimmune encephalitis in children
Han, J. Y., Kim, S. Y., Kim, H., Hwang, H. Y., Choi, J., Chae, J., Kim, K. J., Cheon, J., & Lim, B. C. (2022) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15174 · Cited by 14
Late onset neuromyelitis optica spectrum disorders (LONMOSD) from a nationwide Portuguese study: Anti-AQP4 positive, anti-MOG positive and seronegative subgroups
Santos, E., Moura, J., Samões, R., Sousa, A. P., Mendonça, T., Abreu, P., Guimarães, J., Correia, I., Durães, J., Sousa, L., et al. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103845 · Cited by 14
Comparison of live and fixed cell-based assay performance: implications for the diagnosis of MOGAD in a low-middle income country
Pandit, L., D’Cunha, A., Malli, C., & Sudhir, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1252650 · Cited by 14
Cognitive and psychopathological features of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease: A narrative review
Kazzi, C., Alpitsis, R., O'Brien, T. J., Malpas, C. B., & Monif, M. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105596 · Cited by 14
Epidemiology of neuromyelitis optica spectrum disorder in Denmark (1998–2008, 2007–2014)
Asgari, N., Lillevang, S. T., Skejø, H. P. B., & Kyvik, K. O. (2019) · Brain and Behavior · doi:10.1002/brb3.1338 · Cited by 14
Case Series: Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Related Disease Spectrum
Alshamrani, F., Alnajashi, H. A., Shosha, E., Casserly, C. S., & Morrow, S. A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00089 · Cited by 14
Clinical predictive factors for diagnosis of MOG-IgG and AQP4-IgG related paediatric optic neuritis: a Chinese cohort study
Yang, M. C., Wu, Y., Lai, M., Song, H., Li, H., Sun, M., Xie, L., Zhou, H., Xu, Q., Wei, S., et al. (2020) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-317524 · Cited by 14
Excess weight, central adiposity and pro-inflammatory diet consumption in patients with neuromyelitis optica spectrum disorder
Paz, É. S., Maciel, P. M. C. T., D’Almeida, J. A. C., Silva, B. Y. D. C., Sampaio, H. A. D. C., Pinheiro, A. D. V., Carioca, A. A. F., & de Melo, M. L. P. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103110 · Cited by 14
Hypersensitivity Responses in the Central Nervous System
Khorooshi, R., Asgari, N., Mørch, M. T., Berg, C. T., & Owens, T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00517 · Cited by 13
Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorders and Related Disorders in Resource‐Limited Settings: Outcomes in a Multiethnic Single‐Center Population
Ong, Z. M., Schee, J. P., & Viswanathan, S. (2019) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13446 · Cited by 14
A highly specific and sensitive nanoimmunosensor for the diagnosis of neuromyelitis optica spectrum disorders
Moraes, A. D. S., Brum, D. G., Ierich, J. C. M., Higa, A. M., de Assis, A. S. J., Miyazaki, C. M., Shimizu, F. M., Peroni, L. A., Machini, M. T., Barreira, A. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52506-w · Cited by 14
Quantitative brain lesion distribution may distinguish MOG-ab and AQP4-ab neuromyelitis optica spectrum disorders
Yang, L., Li, H., Xia, W., Quan, C., Zhou, L., Geng, D., & Li, Y. (2019) · European Radiology · doi:10.1007/s00330-019-06506-z · Cited by 15
Neuromyelitis optica and neuromyelitis optica spectrum disorders
Simaniv, T. O., Vasiliev, A. V., Аскарова, Л. Ш., & Zakharova, M. N. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201911910235 · Cited by 16
Allogeneic haematopoietic stem cell transplantation in a refractory case of neuromyelitis optica spectrum disorder
Hau, L., Kállay, K. M., Kertész, G., Goda, V., Kassa, C., Horváth, O. N., Liptai, Z., Constantin, T., & Kriván, G. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102110 · Cited by 14
Seasonal distribution of attacks in aquaporin-4 antibody disease and myelin-oligodendrocyte antibody disease
dos Passos, G. R., Elsone, L., Luppe, S., Kitley, J., Messina, S., Cruz, P. M. R., Harding, K. E., Mutch, K., Leite, M. I., Robertson, N. P., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116881 · Cited by 14
Contemporary management challenges in seropositive NMOSD
Costello, F., & Burton, J. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11241-5 · Cited by 14
Recurrent Optic Neuritis Associated With MOG Antibody Seropositivity
Chang, T., Waters, P. J., Woodhall, M. R., & Vincent, A. C. (2017) · The Neurologist · doi:10.1097/nrl.0000000000000122 · Cited by 13
Serum Proteomics Distinguish Subtypes of NMO Spectrum Disorder and MOG Antibody-Associated Disease and Highlight Effects of B-Cell Depletion
Gawde, S., Siebert, N., Ruprecht, K., Kumar, G., Ko, R. M., Massey, K., Guthridge, J. M., Mao‐Draayer, Y., Schindler, P., Hastermann, M., et al. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200268 · Cited by 13
MRI management of NMOSD and MOGAD: Proposals from the French Expert Group NOMADMUS
Durand‐Dubief, F., Shor, N., Audoin, B., Bourre, B., Cohen, M., Kremer, S., Maillart, É., Papeix, C., Ruet, A., Savatovsky, J., et al. (2024) · Journal of Neuroradiology · doi:10.1016/j.neurad.2024.101235 · Cited by 13
Update on diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) — recommendations of Section of Multiple Sclerosis and Neuroimmunology of Polish Neurological Society
Zakrzewska‐Pniewska, B., Bartosik-Psujek, H., Brola, W., Gołębiowski, M., Kalinowska, A., Kułakowska, A., Mirowska-Guzel, D. M., Nojszewska, M., Podlecka‐Piętowska, A., Stasiołek, M., et al. (2024) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.100945 · Cited by 18
Investigation-Directed Approach to Inflammatory Optic Neuropathies
Boudreault, K., Durand, M. L., & Rizzo, J. F. (2016) · Seminars in Ophthalmology · doi:10.3109/08820538.2015.1114835 · Cited by 13
MOG-IgG associated optic neuritis is not multiple sclerosis
da Costa, B. K., dos Passos, G. R., Becker, J., & Sato, D. K. (2017) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20170121 · Cited by 13
Positive anti-MOG antibodies in a patient with Sjögren's syndrome and transverse myelitis
Jobling, K., Ledingham, D., Ng, W., & Guadagno, J. (2018) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2018.18041 · Cited by 13
A prospective, observational study on conversion of clinically isolated syndrome to multiple sclerosis during 4-year period (MS NEO study) in Taiwan
Ro, L., Yang, C., Lyu, R., Lin, K., Tsai, T.-C., Lu, S., Chang, K., Huang, L.-C., & Tsai, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0202453 · Cited by 13
Anti-MOG and Anti-AQP4 positive neuromyelitis optica spectrum disorder in a patient with myasthenia gravis
Bates, M. C., Chisholm, J., Miller, E., Avasarala, J., & Guduru, Z. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102205 · Cited by 13
Clinical analysis of myelin oligodendrocyte glycoprotein antibody–associated demyelination in children: A single-center cohort study in China
Wang, X., Zhao, R., Yang, H., Liu, C., Wang, W., Liu, T., Cui, L., & Chen, D. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103526 · Cited by 13
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina
Rojas, J. I., Pappolla, A., Patrucco, L., Cristiano, E., Míguez, J., Liwacki, S., Tkachuk, V. A., Balbuena, M. E., Vrech, C., Deri, N. H., et al. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06409-w · Cited by 15
Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated disease
Perez-Giraldo, G., Caldito, N. G., & Grebenciucova, E. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1210972 · Cited by 13
Causal associations between prodromal infection and neuromyelitis optica spectrum disorder: A Mendelian randomization study
Wang, L., Zhou, L., ZhangBao, J., Huang, W., Tan, H., Fan, Y., Lü, C., Yu, J. Y., Wang, M., Lu, J., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.16014 · Cited by 14
Understanding Pediatric Neuroimmune Disorder Conflicts: A Neuroradiologic Approach in the Molecular Era
Server, A., Sakinis, T., Pfeiffer, H. C. V., Sandvig, I., Barlinn, J., & Marthinsen, P. B. (2020) · Radiographics · doi:10.1148/rg.2020200032 · Cited by 13
Impaired Meningeal Lymphatic Flow in NMOSD Patients With Acute Attack
Wang, X., Tian, H., Liu, H., Liang, D., Qin, C., Zhu, Q., Lin, M., Fu, Y., Xu, S., Zhai, Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.692051 · Cited by 13
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Pathophysiology, Clinical Patterns, and Therapeutic Challenges of Intractable and Severe Forms
Misu, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178538 · Cited by 12
Clinical and Radiological Features of Myelin Oligodendrocyte Glycoprotein-Associated Myelitis in Adults
Kim, K. H., Kim, S., Hyun, J., & Kim, H. J. (2022) · Journal of Clinical Neurology · doi:10.3988/jcn.2022.18.3.280 · Cited by 12
Double seropositive neuromyelitis optica associated with COVID-19: A case report
Antonescu-Ghelmez, D., Moraru, A., Antonescu, F., Chelmambet, A. S., Bucur, A. I., & Tuță, S. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1004132 · Cited by 12
Clinical characteristic of myelin oligodendrocyte glycoprotein antibody associated cortical encephalitis in adults and outcomes following glucocorticoid therapy
Wu, Y., Zhou, H. F., Ci, X., Lin, L., Zhang, D., & Lu, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1076361 · Cited by 12
The Role of MRI in Differentiating Demyelinating and Inflammatory (not Infectious) Myelopathies
Tamanini, J. V. G., Sabino, J. V., Cordeiro, R. A., Mizubuti, V., Villarinho, L. D. L., Duarte, J. Á., Pereira, F. V., Appenzeller, S., Damasceno, A., & Reis, F. (2023) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2023.03.017 · Cited by 14
AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?
Fragoso, D. C., Salles, L., Apóstolos‐Pereira, S. L., Callegaro, D., Sato, D. K., & Rimkus, C. D. M. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1768669 · Cited by 12
Associations between neuromyelitis optica spectrum disorder, Sjögren's syndrome, and conditions with electrolyte disturbances
Akaishi, T., Tarasawa, K., Matsumoto, Y., Sandhya, P., Misu, T., Fushimi, K., Takahashi, T., Fujimori, J., Ishii, T., Fujimori, K., et al. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.120742 · Cited by 12
Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis
Vlad, B., Reichen, I., Neidhart, S., Hilty, M., Lekaditi, D., Heuer, C., Eisele, A., Ziegler, M., Reindl, M., Lutterotti, A., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1237149 · Cited by 17
Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated disease
Kang, Y., Ju, H., Kim, K. H., Choo, S. H., Ju, W., Kim, S., Kim, S., Sohn, E. H., Nam, T., Oh, S., et al. (2025) · Multiple Sclerosis Journal · doi:10.1177/13524585251320046 · Cited by 12
Reversible paraspinal muscle hyperintensity in anti-MOG antibody–associated transverse myelitis
Pandit, L., Mustafa, S., Uppoor, R., Nakashima, I., Takahashi, T., & Kaneko, K. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000412 · Cited by 12
Chloride imbalance between serum and CSF in the acute phase of neuromyelitis optica
Akaishi, T., Takahashi, T., & Nakashima, I. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.12.019 · Cited by 12
Neuropsychological Phenotypes of Pediatric Anti-Myelin Oligodendrocyte Glycoprotein Associated Disorders: A Case Series
Tan, A., Marcus, D. J., Howarth, R. A., & Gombolay, G. Y. (2021) · Neuropediatrics · doi:10.1055/s-0041-1723955 · Cited by 12
Detection of MOG-IgG in Clinical Samples by Live Cell-Based Assays: Performance of Immunofluorescence Microscopy and Flow Cytometry
Marchionatti, A., Hansel, G., Avila, G. U., & Sato, D. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642272 · Cited by 12
Electroclinical features of seizures in myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis: A case report and literature review
Tokumoto, K., Nishida, T., Kawaguchi, N., Kaneko, K., Takahashi, T., & Takahashi, Y. (2022) · Seizure · doi:10.1016/j.seizure.2022.04.001 · Cited by 12
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: Presentation and outcomes of adults at a single center
Sutton, P., Lutz, M. W., Hartsell, F., Kimbrough, D. J., Tagg, N. T., Skeen, M. B., Hudak, N. M., Eckstein, C. P., & Shah, S. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577987 · Cited by 12
Methyl-CpG-Binding Protein 2 Emerges as a Central Player in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
Mehmood, A., Shah, S., Guo, R., Haider, A., Shi, M., Ali, H., Ali, I., Ullah, R., & Li, B. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01432-7 · Cited by 14
Myelin Oligodendrocyte Glycoprotein Antibody Persistency in a Steroid-Dependent ADEM Case
Polat, İ., Yiş, U., Karaoğlu, P., Ayanoğlu, M., Öztürk, T., Güleryüz, H., & Kurul, S. H. (2016) · PEDIATRICS · doi:10.1542/peds.2015-1958 · Cited by 12
Pure spinal multiple sclerosis: A possible novel entity within the multiple sclerosis disease spectrum
Schee, J. P., & Viswanathan, S. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458518775912 · Cited by 14
Brain MRI features of Chinese Han patients with MOG-antibody disease
Li, H., Yang, L., Wu, Z., Zhou, L., Bao, Y., Geng, D., Quan, C., & Li, Y. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102167 · Cited by 12
Metabolomic Profiling in Neuromyelitis Optica Spectrum Disorder Biomarker Discovery
Thoman, M. E., & McKarns, S. C. (2020) · Metabolites · doi:10.3390/metabo10090374 · Cited by 12
Pediatric demyelinating disease and anti‐MOG antibody
Tenembaum, S. N. (2021) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12627 · Cited by 12
Diagnostic implications of MOG/AQP4 antibodies in recurrent optic neuritis
Peng, Y., Liu, L., Zheng, Y., Qiao, Z., Feng, K., & Wang, J. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6273 · Cited by 11
Anti-NMDA receptor encephalitis and MOG-associated demyelination – a case report with long-term follow-up and a systematic review
Berek, K., Grams, A. E., Uprimny, C., Prieschl, M., Ramberger, M., Unterberger, I., Deisenhammer, F., Reindl, M., & Hegen, H. (2022) · BMC Neurology · doi:10.1186/s12883-022-02974-x · Cited by 11
Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypes
Manzano, G. S., Levy, M., Salky, R., Mateen, F. J., Klawiter, E. C., Chitnis, T., Vasileiou, E. S., Sotirchos, E. S., Gibbons, E. L., Huda, S., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12585-w · Cited by 11
Early rituximab versus escalating therapy in neuromyelitis optica: A cost and quality of life analysis
Silva, G. D., Apóstolos‐Pereira, S. L., Boaventura, M., Paolilo, R. B., Matos, A. D. M. B., Pitombeira, M. S., Adoni, T., Sato, D. K., & Callegaro, D. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.106160 · Cited by 11
Induction of immune tolerance in NMOSD and MOGAD
Correale, J. D., & Contentti, E. C. (2025) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864251357393 · Cited by 11
The Clinical Spectrum of Autoimmune-Mediated Neurological Diseases in Paediatric Population
Lubarski, K., Mania, A., Michalak, S., Osztynowicz, K., Mazur‐Melewska, K., & Figlerowicz, M. (2022) · Brain Sciences · doi:10.3390/brainsci12050584 · Cited by 11
MR imaging in children with transverse myelitis and acquired demyelinating syndromes
Naggar, I. E., Cleaveland, R., Wendel, E., Bertolini, A., Schanda, K., Karenfort, M., Thiels, C., Marina, A. D., Schimmel, M., Leiz, S., et al. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104068 · Cited by 11
Paracentral Acute Middle Maculopathy Associated with Severe Anti-Mog (Myelin Oligodendrocyte Glycoprotein)-Positive Optic Neuritis
Fernandes, R. D., Andrade, T. D. S., Preti, R. C., Zacharias, L. C., Silva, G. D., Lucato, L. T., Apóstolos‐Pereira, S. L., Callegaro, D., & Monteiro, M. L. R. (2023) · Neuro-Ophthalmology · doi:10.1080/01658107.2023.2172434 · Cited by 11
Reshaping neuroimmunology: diagnosis and treatment in the era of precision medicine
dos Passos, G. R., Adoni, T., Mendes, M. F., & Sato, D. K. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1777752 · Cited by 12
NMO spectrum disorders: clinical or molecular classification?
Pittock, S. J. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.9 · Cited by 11
Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder
Ungureanu, A., Seze, J. D., Ahle, G., & Sellal, F. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.01.378 · Cited by 11
Myelin Oligodendrocyte Glycoprotein (MOG)-IgG Associated Demyelinating Disease
Pujari, S. S., Kulkarni, R. V., Nadgir, D., Ojha, P., Nagendra, S., Aglave, V., Nadgir, R. D., Sant, H., Palasdeokar, N., Nirhale, S. P., et al. (2020) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_627_19 · Cited by 11
Isolated cranial neuritis of the oculomotor nerve: Expanding the MOG phenotype?
Kawakami, S., Akamine, S., Chong, P. F., Yamashita, F., Maeda, K., Takahashi, T., & Kira, R. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102040 · Cited by 11
Postinfectious Acute Disseminated Encephalomyelitis Associated With Antimyelin Oligodendrocyte Glycoprotein Antibody
Sato, R., Okanari, K., Maeda, T., Kaneko, K., Takahashi, T., & Ihara, K. (2020) · Child Neurology Open · doi:10.1177/2329048x20942442 · Cited by 11
Acute and subacute myelopathy
Marignier, R. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.08.003 · Cited by 13
The Impact of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorder Beyond Infection Risk
Yin, H., Zhang, Y., Xu, Y., Peng, B., Cui, L., & Zhang, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.657037 · Cited by 11
Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies
Yang, E., Husein, A., Martinez-Perez, J., & Li, T. (2022) · Case Reports in Neurological Medicine · doi:10.1155/2022/1068227 · Cited by 11
Central nervous system inflammation across the age span
Bar‐Or, A., & Antel, J. P. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000331 · Cited by 11
Retinal Morphology and Sensitivity Are Primarily Impaired in Eyes with Neuromyelitis Optica Spectrum Disorder (NMOSD)
Akiba, R., Yokouchi, H., Mori, M., Oshitari, T., Baba, T., Sawai, S., Kuwabara, S., & Yamamoto, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167473 · Cited by 11
Anti-myelin oligodendrocyte glycoprotein (MOG) antibody-positive varicella-zoster virus myelitis presenting as longitudinally extensive transverse myelitis: a case report
Shiga, Y., Kamimura, T., Shimoe, Y., Takahashi, T., Kaneko, K., & Kuriyama, M. (2017) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001066 · Cited by 11
New biological agents in the treatment of multiple sclerosis
Buc, M. (2018) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2018_035 · Cited by 11
Optic neuritis: pathophysiology, clinical features, and diagnosis
Lee, Y. H. (2024) · Journal of Korean Medical Association · doi:10.5124/jkma.2024.67.8.507 · Cited by 11
Myelin oligodendrocyte glycoprotein antibody-associated disorders: clinical spectrum, diagnostic evaluation, and treatment options
Lee, Y., Nam, S. O., Ko, A., Kong, J., & Byun, S. Y. (2020) · Korean Journal of Pediatrics · doi:10.3345/cep.2019.01305 · Cited by 10
Serum proteins for monitoring and predicting visual function in patients with recent optic neuritis
Kim, H. J., Lee, E., Kim, S., Kim, H., Kim, K., Kim, S., Kim, H., Seo, D., Lee, B. J., Lim, H. T., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-32748-5 · Cited by 10
Free thyroxine level is associated with both relapse rate and poor neurofunction in first-attack Neuromyelitis Optica Spectrum Disorder (NMOSD) patients
He, Q., Li, L., Li, Y., Lu, Y., Wu, K., Zhang, R., Teng, J., Zhao, J., & Jia, Y. (2019) · BMC Neurology · doi:10.1186/s12883-019-1560-7 · Cited by 10
Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein IgG associated disorder: A comprehensive neuro‐ophthalmic review
Sharma, J., Bhatti, M. T., & Danesh-Meyer, H. V. (2021) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13863 · Cited by 11
The Immediate Onset of Isolated and Unilateral Abducens Nerve Palsy Associated with COVID-19 Infection: A Case Report and Literature Review
Kubota, T., Sugeno, N., Sano, H., Murakami, K., Ikeda, K., Misu, T., & Aoki, M. (2022) · Internal Medicine · doi:10.2169/internalmedicine.9308-22 · Cited by 10
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Diseases
Hümmert, M. W., Bütow, F., Tkachenko, D. P., Ayzenberg, I., Pakeerathan, T., Hellwig, K., Klotz, L., Häußler, V., Stellmann, J., Warnke, C., et al. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200082 · Cited by 10
Clinical spectrum of myelin oligodendrocyte glycoprotein antibody-associated disease in Brazil: a single-center experience
Messias, K., Moreto, R., Cruz, C. D. A., Ronchi, N. R., dos Santos, A. C., Messias, A. M. V., & Marques, V. D. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1777002 · Cited by 11
Anti-myelin oligodendrocyte glycoprotein antibodies: Magnetic resonance imaging findings in a case series and a literature review
Cellina, M. I., Vincenza, F., Ciocca, M., Pirovano, M., & Oliva, G. (2017) · The Neuroradiology Journal · doi:10.1177/1971400917698856 · Cited by 10
Analysis of brain and spinal cord lesions to occult brain damage in seropositive and seronegative neuromyelitis optica
Sun, J., Sun, X., Zhang, N., Wang, Q., Cai, H., Qi, Y., Li, T., Qin, W., & Yu, C. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.07.002 · Cited by 10
Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein
Ducloyer, J., Michel, L., Wiertlewski, S., & Lebranchu, P. (2018) · European Journal of Ophthalmology · doi:10.1177/1120672118784797 · Cited by 10
Optic neuritis at disease onset predicts poor visual outcome in neuromyelitis optica spectrum disorders
Amaral, J. M. S. S., Talim, N. C., Kleinpaul, R. G. V., & Lana–Peixoto, M. A. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102045 · Cited by 10
Early age of onset predicts severity of visual impairment in patients with neuromyelitis optica spectrum disorder
Macaron, G., Khoury, J., Bena, J., Seay, M. D., Bermel, R. A., Cohen, J. A., & Rensel, M. R. (2021) · Multiple Sclerosis Journal · doi:10.1177/1352458520981736 · Cited by 10
The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real‐world study from Turkey
Uzunköprü, C., Tütüncü, M., Gündüz, T., Gümüş, H., Şen, S., Demir, S., Çınar, B. P., Türe, H. S., Uygunoğlu, U., Toğrol, E., et al. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14158 · Cited by 10
COVID-19 Vaccine—A Potential Trigger for MOGAD Transverse Myelitis in a Teenager—A Case Report and a Review of the Literature
Mărginean, C. O., Meliţ, L. E., Cucuiet, M. T., Cucuiet, M., Raţiu, M., & Săsăran, M. O. (2022) · Children · doi:10.3390/children9050674 · Cited by 10
Distal cord-predominant longitudinally extensive myelitis with diffuse spinal meningitis and dural abscesses due to occult tuberculosis: A rare occurrence
Sood, I., Kasundra, G., Bhushan, B., Bhargava, A., & Shubhkaran, K. (2016) · Journal of Pediatric Neurosciences · doi:10.4103/1817-1745.181268 · Cited by 10
Anti myelin oligodendrocyte glycoprotein associated immunoglobulin G (AntiMOG-IgG)-associated neuromyelitis optica spectrum disorder with persistent disease activity and residual cognitive impairment
Pandit, L., Nakashima, I., Mustafa, S., Takahashi, T., & Kaneko, K. (2017) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_250_17 · Cited by 10
Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population
Silveira, F., Pappolla, A., Sánchez, F., Marques, V. D., de Castillo, I. S., Tkachuk, V. A., Caride, A., Castillo, M. C., Cristiano, E., Cruz, C. D. A., et al. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102049 · Cited by 11

Authors: Sato, D. K., Callegaro, D., Lana-Peixoto, M. A., Waters, P. J., Jorge, F. M. D. H., Takahashi, T., Nakashima, I., Apostolos-Pereira, S. L., Talim, N., Simm, R. F., Lino, A. M. M., Misu, T., Leite, M. I., Aoki, M., & Fujihara, K.
Affiliations: Universidade Federal de Minas Gerais (BR)
From the Departments of Neurology (D.K.S., T.T., I.N., M.A.) and Multiple Sclerosis Therapeutics (T.M., K.F.), Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurology (D.C., F.M.d.H.J., S.L.A.-P., R.F.S., A.M.M.L.), Faculty of Medicine, University of São Paulo, Brazil; CIEM MS Research Center (M.A.L.-P., N.T.), Federal University of Minas Gerais Medical School, Belo Horizonte, Brazil; Neuroimmunology Group (P.J.W., M.I.L.), Nuffield Department of Clinical Neurosciences,...
ORCID: Sato, Douglas Kazutoshi
Callegaro, Dagoberto
Waters, Patrick J.
Takahashi, Toshiyuki
Nakashima, Ichiro
Lino, Angelina Maria Martins
Misu, Tatsuro
Leite, Maria Isabel
Aoki, Masashi
Fujihara, Kazuo
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2014-02-11
Volume: 82
Issue: 6
Pages: 474-481
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.0000000000000101
PMC: PMC3937859
OpenAlex: W2103812851
Cited by: 850
References: 21
Citations by year: 2026: 25 · 2025: 41 · 2024: 45 · 2023: 67 · 2022: 69 · 2021: 94 · 2020: 95 · 2019: 83 · 2018: 76 · 2017: 82 · 2016: 66 · 2015: 66 · 2014: 38
FWCI: 62.41
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
Locations: Neurology (publishedVersion, cc-by-nc-nd)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Japan Society for the Promotion of Science (22229008)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords: neuromyelitis optica spectrum disorder, anti-MOG antibodies, aquaporin-4 antibodies, seronegative NMOSD, clinical features, optic neuritis, spinal cord lesions, disease phenotypes, functional recovery, relapse rate
MeSH terms: Adolescent, Adult, Aged, Autoantibodies, Child, Preschool, Female, Humans, Male, Middle Aged, Neuromyelitis Optica, Phenotype, Sex Factors, Aquaporin 4, Young Adult, Myelin-Oligodendrocyte Glycoprotein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks